Liver Disease
CAMBRIDGE, Mass. - Vertex Pharmaceuticals Inc.
ST. LOUIS - The Veterans Administration says the chief of dental services at a St.
ST. LOUIS - Several members of Congress have demanded that a St.
NEW YORK - The drugmaker Teva said Friday it won't make any more of its sedative propofol, which could intensify a shortage of one of the most common anesthetics in the U.S.
NEW YORK - The drugmaker Teva said Friday it won't make any more of its sedative propofol, which could intensify a shortage of an anesthetic widely used in operating rooms.
More News
- Teva says it will stop making propofol sedative
- Jury awards $500M punitive damages in hep C case
- Vitamin E shows promise for treating liver disease
- Pfizer ends trial of Sutent in liver cancer
- Regulus and Glaxo will work on hepatitis C drugs
- Ahead of the Bell: Anadys hepatitis C drug
- Achillion rises on hepatitis/HIV drug pact
- Vertex to ask for telaprevir OK later in 2010
- Achillion shares rise on hepatitis C drug data
